"Therapeutic Strategies in Heart Failure" is a pragmatic textbook written by active clinicians and investigators that is sharply focused on what the doctor needs to know to achieve the best possible outcome in patients with heart failure. The authors have incorporated all of the most recent definitive trial data, in a user friendly format, with frequent summary boxes and highlighted points of emphasis. The book begins with the prevention of heart failure, discusses best application of standard therapies, describes progress with current cutting edge treatments, and anticipates future therapeutic interventions. To complete the thought process, the final section deals with the avant garde issues in heart failure - the use of registry data, acute decompensated heart failure, device therapy, mechanical support for failing ventricles and a candid discussion of palliative care. The busy clinician is likely to find that "Therapeutic Strategies in Heart Failure" provides a useful template to optimize outcomes in the management of heart failure.
Part I: Preventive therapies for chronic heart failure; 1. The prevention of heart failure, S Nesbitt; 2. Left ventricular hypertrophy, M Drazner; 3. Addressing the metabolic syndrome, R Shannon; 4. Post MI left ventricular dysfunction, E Velasquez; Part II: Established pharmacological therapies for chronic heart failure; 5. Diuretic therapy in heart failure, C Yancy; 6. Digoxin therapy in heart failure, J Kalman; 7. Neurohormonal activation in heart failure: ACE inhibitors, D Markham; 8. Neurohormonal activation in heart failure: angiotensin receptor antagonists, M Felker; 9. Neurohormonal activation in heart failure: aldosterone antagonists, R Starling; 10. Neurohormonal activation in heart failure: beta blockers, S Kamath; Part III: Emerging pharmacological therapies for heart failure; 11. Nitric oxide biology and oxidative stress in heart failure, C Yancy; 12. B-type natriuretic peptides in heart failure, T Heywood; Part IV: Future pharmacological therapies for heart failure; 13. Arginine vasopressin antagonism in heart failure, J Udelson; 14. New inotropes in heart failure - the potential use of CA++ sensitization, K Aaronson; 15. Extracellular remodeling in heart failure; the potential use of MMP inhibitors, D Feldman; 16. Erythropoietin analogues, S Katz; Part V: Special topics in heart failure; 17. Applying data from registries to improve outcomes in heart failure, G Fonarow; 18. Acute decompensated heart failure - management considerations, M Shah; 19. Device therapy in heart failure, P Adamson; 20. Ventricular replacement therapy for heart failure, R Bogaev; 21. Hospice and palliative care in heart failure, P Hauptman.
